☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
US Rights
Clinigen Licenses Commercialization Rights for Proleukin from Novartis in the US
February 14, 2019
AstraZeneca Divests US Rights of Synagis & MEDI8897 to Sobi for Prevention of Serious Lower Respiratory Tract infection (LRTI)
November 13, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
